M. Thill

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIP Michelangelo randomized study.

P. Valagussa, S. Russo, R. Greil, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

LBA14 Impact of age, recurrence score (RS) and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Analysis of ADAPT and ADAPTcycle trials

O. Gluz, S. Kuemmel, A. Hartkopf, 2022, Annals of Oncology.

AXSANA – AXillary Surgery After NeoAdjuvant Treatment (EUBREAST-3): current status of the international prospective multicenter cohort study evaluating different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655

T. Kühn, E. Schlichting, E. Stickeler, 2022, Senologie - Zeitschrift für Mammadiagnostik und -therapie.

Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry

T. Fehm, C. Denkert, V. Nekljudova, 2022, ESMO open.

Patient Reported Outcome and cosmetic evaluation following implant-based breast-reconstruction with a titanized polypropylene mesh (TiLOOP® Bra): a prospective clinical study in 269 patients

R. Ohlinger, S. Paepke, H. Strittmatter, 2020, Geburtshilfe und Frauenheilkunde.

LBA12 Predictive value of gene-expression profiles (GEPs) and their dynamics during therapy in the NeoTRIPaPDL1 trial

B. Győrffy, M. Dugo, M. Callari, 2021, Annals of Oncology.

Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry

T. Fehm, C. Denkert, V. Nekljudova, 2022, ESMO open.

Stewart-Treves Syndrome – A Rare Complication after Radical Vulvectomy – A Case Report

C. Jackisch, C. Fuhljahn, S. Braun, 2006 .